華富財經 Quamnet.com Logo
新聞
2020-09-16 14:34:58
SINO BIOPHARM's drug gets approval for new indication

(Infocast News) Sino Biopharmaceutical Limited (01177) announced that “Spironolactone Tablets”, a diuretic developed by the group, has obtained the notice of approval of supplemental applications issued by the National Medical Products Administration of the PRC, approving the addition of specification of 100mg (the first domestic specification of its kind) and new indication, applicable to the treatment of heart failure, hypertension, edema related to liver cirrhosis and nephrotic syndrome, as well as primary aldosteronism.

(WL)